Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Alembic Pharmaceuticals Limited
Press Release Feb 01 2022
Business
Feb 1 2022
3 min read

Press Release Feb 01 2022

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 01, 2022, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Clarithromycin Tablets USP, 250 mg and 500 mg".

View Attachment